Microglia/Brain Macrophages as Central Drivers of Brain Tumor Pathobiology

David H Gutmann1, Helmut Kettenmann2

  • 1Department of Neurology, Washington University School of Medicine, St. Louis, MO 63110, USA.

Neuron
|November 8, 2019
PubMed

Insights

Gliomas, common brain tumors, have limited treatments. This review explores how microglia and macrophages influence glioma development, progression, and treatment response.

Area of Science:

  • Neuro-oncology
  • Cancer Biology
  • Immunology

Background:

  • Gliomas, including astrocytomas, are prevalent brain tumors in children and adults.
  • Malignant glioma patients exhibit poor prognoses despite aggressive multimodal therapies.
  • Tumor microenvironments comprise diverse neoplastic and non-neoplastic cells impacting tumor behavior.

Purpose of the Study:

  • To review the multifaceted roles of microglia and macrophages in glioma.
  • To elucidate the interactions between monocytes and glioma cells.
  • To understand how these interactions affect glioma formation, progression, and therapeutic outcomes.

Main Methods:

  • Literature review of studies on glioma and myeloid cell interactions.
  • Analysis of research on microglia and macrophage functions in the tumor microenvironment.
  • Synthesis of findings on the impact of these cells on glioma biology.

Main Results:

  • Monocytes, specifically microglia and macrophages, are predominant non-cancerous cells within gliomas.
  • These myeloid cells engage in complex interactions influencing tumor initiation and growth.
  • Microglia and macrophages play critical roles in modulating response to glioma therapies.

Conclusions:

  • Targeting microglia and macrophages presents a potential therapeutic strategy for glioma.
  • Understanding myeloid cell dynamics is crucial for improving glioma treatment efficacy.
  • Further research into glioma-immunology interactions may yield novel therapeutic avenues.